pan Cytokeratin Antibody (AE1 + AE3)


Immunohistochemistry-Paraffin: pan Cytokeratin Antibody (AE1 + AE3) [NBP2-29429] - Formalin-paraffin colon carcinoma stained with pan Cytokeratin Ab cocktail (AE-1 / AE3).
Flow Cytometry: pan Cytokeratin Antibody (AE1 + AE3) [NBP2-29429] - Human Pan-Cytokeratins on HeLa Cells. Black: Cells alone; Green: Isotype Control; Red: PE-labeled Pan-Cytokeratin Monoclonal Antibody (AE-1/AE-3)

Product Details

Reactivity Hu, Mu, Rt, Bv, Ca, Ch, Pm, RbSpecies Glossary
Applications WB, Flow, ICC/IF, IHC-Fr, IHC-P
AE1 + AE3
Please see the vial label for concentration. If unlisted please contact technical services.

pan Cytokeratin Antibody (AE1 AE3) Summary

Total keratin isolated from human epidermal callus was used as immunogen to generate the pan cytokeratin antibodies AE1 + AE3 (Woodcock-Mitchell, 1982).
Epithelial marker
Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include CK1, CK3, CK4, CK5, CK6, CK8, CK10, CK14, CK15, CK16, and CK19. Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. AE-1/AE-3 is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas.
Protein A or G purified
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.

Packaging, Storage & Formulations

Store at 4C. Do not freeze.
10mM PBS and 0.05% BSA
0.05% Sodium Azide
Protein A or G purified


  • Western Blot 0.5-1ug/ml
  • Flow Cytometry 0.5-1ug/million cells
  • Immunocytochemistry/Immunofluorescence 1-2ug/ml
  • Immunohistochemistry-Frozen 0.5-1.0ug/ml
  • Immunohistochemistry-Paraffin 0.5-1.0ug/ml
Application Notes
Mol. Weight of Antigen: 40 - 67 kDa
1. The staining pattern of the pan cytokeratin antibody cocktail may be different than that of either antibody separately.
2. The pan cytokeratin cocktail does not react with keratin18, which is also expressed in carcinomas. As such, negative staining with NBP2-29429 in of itself may not be sufficient evidence to rule out the possibility of a carcinoma (Ordonez, 2013).
a. For example, hepatocellular, adrenal cortical, clear cell renal and chromophobe renal cell carcinomas have been reported to be negative for the pan cytokeratin antibody. In this regard, the pan cytokeratin antibody can be used as part of a screening panel to more extensively define the tumor cell lineages.
3. The pan cytokeratin antibody may cross-react with GFAP, leading to aberrant positive staining of glial tumors such as ependymoma, glioblastoma, or schwannoma (Ordonez, 2013).
Read Publications using
NBP2-29429 in the following applications:


Keratin/cytokeratin AE1 + AE3 is a pan cytokeratin (also known as pan keratin) antibody cocktail that detects cytokeratins 1-8, 10, 14-16 and 19 (reviewed in Ordonez, 2013). The cocktail is an optimized mixture of two different monoclonal antibody clones, AE1 and AE3. Each clone detects a subset of high and low molecular weight cytokeratins: AE1 detects 10, 14-16, and 19; AE3 detects 1-8. A key advantage of the pan cytokeratin antibody cocktail stain is that a broader spectrum of cytokeratins can be detected compared to using each clone alone.
The pan cytokeratin antibody cocktail is a well known broad spectrum immunohistochemical epithelial marker for screening for epithelial differentiation in tumors and their metastases. Most carcinomas have been reported to stain positive, and the antibody can help confirm or rule out the epithelial nature of a poorly differentiated tumor. Positive pan cytokeratin staining with the antibody in the lymph node (Nikura, 2007) or bone marrow ((Berg, 2007) can be an indication of metastatic carcinoma. The pan cytokeratin antibody has also been used to identify residual tumor post-treatment (Azumi, 2006), assess the depth of cancerous invasion (Alexander-Sefre, 2004) and predict survival outcome (Wiedswang, 2004).
Negative pan cytokeratin staining patterns can suggest non-epithelial components associated with a carcinoma. For example, ductal lavage foam cells from breast carcinoma patients did not stain with the antibody (Krishnamurthy, 2002). Foam cells are apparently of macrophage origin and hence pan cytokeratin cocktail negative.
The pan cytokeratin antibody staining patterns have been extensively documented in epithelium and numerous tumor types, dating back to 1982 (Woodcock-Mitchell) when the clones were first developed. As such, researchers are encouraged to survey the published literature for additional information about pan cytokeratin positive and negative staining tumors as well as in normal tissue.


This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Customers Who Viewed This Item Also Viewed...

Species: Hu, Mu, Rt, Po, Ca, Ze
Applications: WB, Flow, ICC/IF, IHC, IHC-Fr
Species: Hu, Mu, Rt
Applications: WB, Simple Western, Flow, ICC/IF, IHC-Fr, IHC-P, IP
Species: Hu, Mu, Mk
Applications: WB, ELISA, Flow, ICC/IF, IHC, IHC-P
Species: Hu, Po, Ca, Pm, Mu(-)
Applications: WB, ELISA, ICC/IF, IHC, IHC-Fr, IHC-P, IP
Species: Hu
Applications: IHC, IHC-P
Species: Hu
Applications: Func, PAGE
Species: Hu
Applications: WB, IHC
Species: Hu, Mu, Bv, Rb
Applications: WB, IHC-Fr, IHC-P
Species: Hu
Applications: WB, ELISA, ICC/IF, IHC, IHC-P, S-ELISA
Species: Hu
Applications: WB, ICC/IF, IHC, IHC-P
Species: Hu, Mu, Rt
Applications: WB, ICC/IF, IHC, IHC-P
Species: Hu
Applications: WB, IHC, IHC-P
Species: Hu
Applications: ICC/IF, IHC, IHC-P
Species: Hu, Mu, Rt
Applications: WB, Simple Western, ICC/IF, IHC, IHC-P
Species: Mu
Applications: WB, ELISA, ICC/IF, IHC, IHC-P
Species: Hu, Mu
Applications: WB, ICC/IF, IHC, IHC-P
Species: Hu, Mu
Applications: WB, ICC/IF, IHC, IHC-P
Species: Hu
Applications: IHC, IHC-P
Species: Hu, Mu, Rt, Mk
Applications: WB, ICC/IF, IHC, IHC-P
Species: Hu, Mu, Rt, Bv, Ca, Ch, Pm, Rb
Applications: WB, Flow, ICC/IF, IHC-Fr, IHC-P

Publications for pan Cytokeratin Antibody (NBP2-29429)(9)

We have publications tested in 2 confirmed species: Human, Lizards.

We have publications tested in 4 applications: ICC, ICC/IF, IHC-P, WB.

Filter By Application
All Applications
Filter By Species
All Species
Showing Publications 1 - 9 of 9.
Publications using NBP2-29429 Applications Species
Ordonez NG. Broad-spectrum immunohistochemical epithelial markers: a review. Hum Pathol. 2013 Jul [PMID:23427873] (IHC-P) IHC-P
Niikura H, Okamoto S, Yoshinaga K et al. Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecol Oncol. 2007 Jun [PMID:17442382] (IHC-P) IHC-P
Berg A, Berner A, Lilleby W et al. Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy. Int J Cancer. 2007 Apr 15 [PMID:17230512] (ICC/IF) ICC/IF
Azumi M, Saga Y, Hashimoto H et al. [Histological investigation of prostate cancer treated with hormonal agents]. Hinyokika Kiyo. 2006 Oct [PMID:17131867]
Wiedswang G, Borgen E, Karesen R et al. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res. 2004 Aug 15 [PMID:15328170]
Alexander-Sefre F, Singh N, Ayhan A et al. Assessment of the depth of myometrial invasion in stage I endometrioid endometrial cancer using pancytokeratin immunohistochemistry. Int J Gynecol Cancer. 2004 Jul-Aug [PMID:15304163] (IHC-P) IHC-P
Krishnamurthy S, Sneige N, Ordonez NG et al. Characterization of foam cells in nipple aspirate fluid. Diagn Cytopathol. 2002 Nov [PMID:12411988] (ICC) ICC
Alibardi L, Maurizii M, Taddei C. Immunocytochemical and electrophoretic distribution of cytokeratins in the resting stage epidermis of the lizard Podarcis sicula. J Exp Zool. 2001 Jun 1 [PMID:11351328] (WB, ICC/IF, Lizards) WB, ICC/IF Lizards
Woodcock-Mitchell J, Eichner R, Nelson WG et al. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol. 1982 Nov [PMID:6183275] (WB, Human) WB Human

Reviews for pan Cytokeratin Antibody (NBP2-29429) (0)

There are no reviews for pan Cytokeratin Antibody (NBP2-29429). By submitting a review earn points towards our Rewards Program.
  • 250 points for product review
  • 500 additional points for an image with your product review
  • Double points (500) if you are the first to review this product
  • Double points (1000) if you are the first to review this product with an image

Product General Protocols

Video Protocols

WB Video Protocol
ICC/IF Video Protocol

FAQs for pan Cytokeratin Antibody (NBP2-29429) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Secondary Antibodies


Isotype Controls

Additional pan Cytokeratin Antibody (AE1 AE3) Products

pan Cytokeratin NBP2-29429

Related Products by Gene

Bioinformatics Tool for pan Cytokeratin Antibody (NBP2-29429)

Discover related pathways, diseases and genes to pan Cytokeratin Antibody (NBP2-29429). Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
Visit Tool

Diseases for pan Cytokeratin Antibody (NBP2-29429)

Discover more about diseases related to pan Cytokeratin Antibody (NBP2-29429).

Pathways for pan Cytokeratin Antibody (NBP2-29429)

View related products by pathway.

PTMs for pan Cytokeratin Antibody (NBP2-29429)

Learn more about PTMs related to pan Cytokeratin Antibody (NBP2-29429).

Research Areas for pan Cytokeratin Antibody (NBP2-29429)

Find related products by research area.

Blogs on pan Cytokeratin

There are no specific blogs for pan Cytokeratin, but you can read our latest blog posts.

Contact Information

Product PDFs


Gene Symbol KRT1

Customer Resources

Novus Review - Submit your review and earn rewards points which can be used for merchandise & discounts.
Risk Free Testing - Test on a species/application not listed above to receive a full credit towards a future purchase.

Novus' Quality Guarantee - Novus guarantees that every product we sell will work in the application and species listed on our website and datasheets.

Submit your question on NBP2-29429 below.
During business hours, we will respond to your email within 24 hours. For any questions submitted on the weekend, a response will be received on Monday.
For immediate assistance during business hours M- F (excluding major holidays), please contact us.
Ask a Scientist - We have a lab full of white coats just waiting for your scientific questions and concerns.

Customers Who Bought This Also Bought

Mouse IgG Isotype Control